Current and emerging pharmacological treatments for sarcoidosis: a review

References

• Hunninghake GW Costabel U Ando M ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders Sarcoidosis Vasc Diffuse Lung Dis 1999 16 2 149 173 10560120
   PubMed Web of Science ®Google Scholar
• Judson MA An approach to the treatment of pulmonary sarcoidosis with corticosteroids: the six phases of treatment Chest 1999 115 4 1158 1165 10208222
   PubMed Web of Science ®Google Scholar
• Judson MA The treatment of pulmonary sarcoidosis Respir Med 2012 106 10 1351 1361 22495110
   PubMed Web of Science ®Google Scholar
• Ohara K Judson MA Baughman RP Clinical aspects of ocular sarcoidosis Eur Respir Mon 2005 10 188 209
   Google Scholar
• Rosen Y Pathology of sarcoidosis Semin Respir Crit Care Med 2007 28 1 36 52 17330191
   PubMed Web of Science ®Google Scholar
• Bell NH Stern PH Pantzer E Sinha TK DeLuca HF Evidence that increased circulating 1 alpha, 25-dihydroxyvitamin D is the probable cause for abnormal calcium metabolism in sarcoidosis J Clin Invest 1979 64 1 218 225 312811
   PubMed Web of Science ®Google Scholar
• Burke RR Rybicki BA Rao DS Calcium and vitamin D in sarcoidosis: how to assess and manage Semin Respir Crit Care Med 2010 31 4 474 484 20665397
   PubMed Web of Science ®Google Scholar
• Sharma OP Renal sarcoidosis and hypercalcemia Eur Respir Mon 2005 32 220 232
   Google Scholar
• Smedema JP Snoep G van Kroonenburgh MP Cardiac involvement in patients with pulmonary sarcoidosis assessed at two university medical centers in The Netherlands Chest 2005 128 1 30 35 16002912
   PubMed Web of Science ®Google Scholar
• Judson MA Gilbert GE Rodgers JK Greer CF Schabel SI The utility of the chest radiograph in diagnosing exacerbations of pulmonary sarcoidosis Respirology 2008 13 1 97 102 18197917
   PubMed Web of Science ®Google Scholar
• Iannuzzi MC Rybicki BA Teirstein AS Sarcoidosis N Engl J Med 2007 357 21 2153 2165 18032765
   PubMed Web of Science ®Google Scholar
• Grutters JC van den Bosch JM Corticosteroid treatment in sarcoidosis Eur Respir J 2006 28 3 627 636 16946094
   PubMed Web of Science ®Google Scholar
• Schutt AC Bullington WM Judson MA Pharmacotherapy for pulmonary sarcoidosis: a Delphi consensus study Respir Med 2010 104 5 717 723 20089389
   PubMed Web of Science ®Google Scholar
• Baughman RP Iannuzzi MC Lower EE Use of fluticasone in acute symptomatic pulmonary sarcoidosis Sarcoidosis Vasc Diffuse Lung Dis 2002 19 3 198 204 12405489
   PubMed Web of Science ®Google Scholar
• Pietinalho A Tukiainen P Haahtela T Persson T Selroos O Early treatment of stage II sarcoidosis improves 5-year pulmonary function Chest 2002 121 1 24 31 11796428
   PubMed Web of Science ®Google Scholar
• Gottlieb JE Israel HL Steiner RM Triolo J Patrick H Outcome in sarcoidosis. The relationship of relapse to corticosteroid therapy Chest 1997 111 3 623 631 9118698
   PubMed Web of Science ®Google Scholar
• Eule H Weinecke A Roth I Wuthe H The possible influence of corticosteroid therapy on the natural course of pulmonary sarcoidosis. Late results of a continuing clinical study Ann N Y Acad Sci 1986 465 695 701 3524366
   PubMed Web of Science ®Google Scholar
• Izumi T Sarcoidosis in Kyoto (1963–1986) Sarcoidosis 1988 5 2 142 146 3227188
   PubMedGoogle Scholar
• Rodrigues SC Rocha NA Lima MS Factor analysis of sarcoidosis phenotypes at two referral centers in Brazil Sarcoidosis Vasc Diffuse Lung Dis 2011 28 1 34 43 21796889
   PubMed Web of Science ®Google Scholar
• Paramothayan NS Lasserson TJ Jones PW Corticosteroids for pulmonary sarcoidosis Cochrane Database Syst Rev 2005 2 CD001114 15846612
   PubMedGoogle Scholar
• Baughman RP Lower EE Kaufman AH Ocular sarcoidosis Semin Respir Crit Care Med 2010 31 4 452 462 20665395
   PubMed Web of Science ®Google Scholar
• Nunes H Freynet O Naggara N Cardiac sarcoidosis Semin Respir Crit Care Med 2010 31 4 428 441 20665393
   PubMed Web of Science ®Google Scholar
• Yazaki Y Isobe M Hiroe M Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone Am J Cardiol 2001 88 9 1006 1010 11703997
   PubMed Web of Science ®Google Scholar
• Hamzeh NY Wamboldt FS Weinberger HD Management of cardiac sarcoidosis in the United States: a Delphi study Chest 2012 141 1 154 162 21737493
   PubMed Web of Science ®Google Scholar
• Lower EE Broderick JP Brott TG Baughman RP Diagnosis and management of neurological sarcoidosis Arch Intern Med 1997 157 16 1864 1868 9290546
   PubMedGoogle Scholar
• Zajicek JP Scolding NJ Foster O Central nervous system sarcoidosis – diagnosis and management QJM 1999 92 2 103 117 10209662
   PubMed Web of Science ®Google Scholar
• Sharma OP Neurosarcoidosis: a personal perspective based on the study of 37 patients Chest 1997 112 1 220 228 9228380
   PubMed Web of Science ®Google Scholar
• Marchell RM Judson MA Cutaneous sarcoidosis Semin Respir Crit Care Med 2010 31 4 442 451 20665394
   PubMed Web of Science ®Google Scholar
• Haimovic A Sanchez M Judson MA Prystowsky S Sarcoidosis: a comprehensive review and update for the dermatologist: part I. Cutaneous disease J Am Acad Dermatol 2012 66 5 699 e691 e618 quiz 717–698 22507585
   PubMed Web of Science ®Google Scholar
• Lazar CA Culver DA Treatment of sarcoidosis Semin Respir Crit Care Med 2010 31 4 501 518 20665400
   PubMed Web of Science ®Google Scholar
• Baughman RP Drent M Kavuru M Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement Am J Respir Critl Care Med 2006 174 7 795 802
   PubMed Web of Science ®Google Scholar
• Lower EE Baughman RP Prolonged use of methotrexate for sarcoidosis Arch Intern Med 1995 155 8 846 851 7717793
   PubMedGoogle Scholar
• Baughman RP Costabel U du Bois RM Treatment of sarcoidosis Clin Chest Med 2008 29 3 533 548 ix x 18539243
   PubMed Web of Science ®Google Scholar
• Baughman RP Culver DA Judson MA A concise review of pulmonary sarcoidosis Am J Respir Crit Care Med 2011 183 5 573 581 21037016
   PubMed Web of Science ®Google Scholar
• Morgan SL Baggott JE Vaughn WH Supplementation with folic acid during methotrexate therapy for rheumatoid arthritis. A double-blind, placebo-controlled trial Ann Intern Med 1994 121 11 833 841 7978695
   PubMed Web of Science ®Google Scholar
• Kalia S Dutz JP New concepts in antimalarial use and mode of action in dermatology Dermatol Ther 2007 20 4 160 174 17970883
   PubMed Web of Science ®Google Scholar
• Baltzan M Mehta S Kirkham TH Cosio MG Randomized trial of prolonged chloroquine therapy in advanced pulmonary sarcoidosis Am Journal Respir Crit Care Med 1999 160 1 192 197 10390399
   PubMed Web of Science ®Google Scholar
• Jones E Callen JP Hydroxychloroquine is effective therapy for control of cutaneous sarcoidal granulomas J Am Acad Dermatol 1990 23 3 Pt 1 487 489 2212149
   PubMed Web of Science ®Google Scholar
• Adams JS Diz MM Sharma OP Effective reduction in the serum 1,25-dihydroxyvitamin D and calcium concentration in sarcoidosis-associated hypercalcemia with short-course chloroquine therapy Ann Internal Med 1989 111 5 437 438 2764407
   PubMed Web of Science ®Google Scholar
• Barre PE Gascon-Barre M Meakins JL Goltzman D Hydroxychloroquine treatment of hypercalcemia in a patient with sarcoidosis undergoing hemodialysis Am J Med 1987 82 6 1259 1262 3605143
   PubMed Web of Science ®Google Scholar
• O’Leary TJ Jones G Yip A Lohnes D Cohanim M Yendt ER The effects of chloroquine on serum 1,25-dihydroxyvitamin D and calcium metabolism in sarcoidosis N Engl J Med 1986 315 12 727 730 3755800
   PubMed Web of Science ®Google Scholar
• Sweiss NJ Patterson K Sawaqed R Rheumatologic manifestations of sarcoidosis Semin Respir Crit Care Med 2010 31 4 463 473 20665396
   PubMed Web of Science ®Google Scholar
• Baughman RP Lower EE Steroid-sparing alternative treatments for sarcoidosis Clin Chest Med 1997 18 4 853 864 9413663
   PubMed Web of Science ®Google Scholar
• Ruckemann K Fairbanks LD Carrey EA Leflunomide inhibits pyrimidine de novo synthesis in mitogen-stimulated T-lymphocytes from healthy humans J Biol Chem 1998 273 34 21682 21691 9705303
   PubMed Web of Science ®Google Scholar
• Sahoo DH Bandyopadhyay D Xu M Effectiveness and safety of leflunomide for pulmonary and extrapulmonary sarcoidosis Eur Respir J 2011 38 5 1145 1150 21565914
   PubMed Web of Science ®Google Scholar
• Baughman RP Lower EE Leflunomide for chronic sarcoidosis Sarcoidosis Vasc Diffuse Lung Dis 2004 21 1 43 48 15127974
   PubMed Web of Science ®Google Scholar
• Smolen JS Emery P Kalden JR The efficacy of leflunomide monotherapy in rheumatoid arthritis: towards the goals of disease modifying antirheumatic drug therapy J Rheumatol Suppl 2004 71 13 20 15170903
   PubMedGoogle Scholar
• Emery P Breedveld FC Lemmel EM A comparison of the efficacy and safety of leflunomide and methotrexate for the treatment of rheumatoid arthritis Rheumatology (Oxford) 2000 39 6 655 665 10888712
   PubMed Web of Science ®Google Scholar
• van Riel PL Smolen JS Emery P Leflunomide: a manageable safety profile J Rheumatol Suppl 2004 71 21 24 15170904
   PubMedGoogle Scholar
• Androdias G Maillet D Marignier R Mycophenolate mofetil may be effective in CNS sarcoidosis but not in sarcoid myopathy Neurology 2011 76 13 1168 1172 21444902
   PubMed Web of Science ®Google Scholar
• Kouba DJ Mimouni D Rencic A Nousari HC Mycophenolate mofetil may serve as a steroid-sparing agent for sarcoidosis Br J Dermatol 2003 148 1 147 148 12534610
   PubMed Web of Science ®Google Scholar
• Bhat P Cervantes-Castaneda RA Doctor PP Anzaar F Foster CS Mycophenolate mofetil therapy for sarcoidosis-associated uveitis Ocul Immunol Inflamm 2009 17 3 185 190 19585361
   PubMed Web of Science ®Google Scholar
• Doty JD Mazur JE Judson MA Treatment of corticosteroid-resistant neurosarcoidosis with a short-course cyclophosphamide regimen Chest 2003 124 5 2023 2026 14605084
   PubMed Web of Science ®Google Scholar
• Chapelon-Abric C de Zuttere D Duhaut P Cardiac sarcoidosis: a retrospective study of 41 cases Medicine 2004 83 6 315 334 15525844
   PubMed Web of Science ®Google Scholar
• Demeter SL Myocardial sarcoidosis unresponsive to steroids. Treatment with cyclophosphamide Chest 1988 94 1 202 203 3383636
   PubMed Web of Science ®Google Scholar
• Sodhi M Pearson K White ES Culver DA Infliximab therapy rescues cyclophosphamide failure in severe central nervous system sarcoidosis Respir Med 2009 103 2 268 273 18835147
   PubMed Web of Science ®Google Scholar
• Haubitz M Schellong S Gobel U Intravenous pulse administration of cyclophosphamide versus daily oral treatment in patients with antineutrophil cytoplasmic antibody-associated vasculitis and renal involvement: a prospective, randomized study Arthritis Rheum 1998 41 10 1835 1844 9778225
   PubMed Web of Science ®Google Scholar
• Somers EC Marder W Christman GM Ognenovski V McCune WJ Use of a gonadotropin-releasing hormone analog for protection against premature ovarian failure during cyclophosphamide therapy in women with severe lupus Arthritis Rheum 2005 52 9 2761 2767 16142702
   PubMed Web of Science ®Google Scholar
• Judson MA Silvestri J Hartung C Byars T Cox CE The effect of thalidomide on corticosteroid-dependent pulmonary sarcoidosis Sarcoidosis Vasc Diffuse Lung Dis 2006 23 1 51 57 16933470
   PubMed Web of Science ®Google Scholar
• Zabel P Entzian P Dalhoff K Schlaak M Pentoxifylline in treatment of sarcoidosis Am J Respir Crit Care Med 1997 155 5 1665 1669 9154873
   PubMed Web of Science ®Google Scholar
• Doty JD Mazur JE Judson MA Treatment of sarcoidosis with infliximab Chest 2005 127 3 1064 1071 15764796
   PubMed Web of Science ®Google Scholar
• Baughman RP Lower EE Infliximab for refractory sarcoidosis Sarcoidosis Vasc Diffuse Lung Dis 2001 18 1 70 74 11354550
   PubMed Web of Science ®Google Scholar
• Fehrenbach H Zissel G Goldmann T Alveolar macrophages are the main source for tumour necrosis factor-alpha in patients with sarcoidosis Eur Respir J 2003 21 3 421 428 12661995
   PubMed Web of Science ®Google Scholar
• Zissel G Muller-Quernheim J Sarcoidosis: historical perspective and immunopathogenesis (Part I) Respir Med 1998 92 2 126 139 9616502
   PubMed Web of Science ®Google Scholar
• Judson MA Baughman RP Costabel U Efficacy of infliximab in extrapulmonary sarcoidosis: results from a randomised trial Eur Respir J 2008 31 6 1189 1196 18256069
   PubMed Web of Science ®Google Scholar
• Stagaki E Mountford WK Lackland DT Judson MA The treatment of lupus pernio: results of 116 treatment courses in 54 patients Chest 2009 135 2 468 476 18812454
   PubMed Web of Science ®Google Scholar
• Panselinas E Rodgers JK Judson MA Clinical outcomes in sarcoidosis after cessation of infliximab treatment Respirology 2009 14 4 522 528 19386069
   PubMed Web of Science ®Google Scholar
• Keane J Gershon S Wise RP Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent N Engl J Med 2001 345 15 1098 1104 11596589
   PubMed Web of Science ®Google Scholar
• Lopez-Olivo MA Tayar JH Martinez-Lopez JA Risk of malignancies in patients with rheumatoid arthritis treated with biologic therapy: a meta-analysis JAMA 2012 308 9 898 908 22948700
   PubMed Web of Science ®Google Scholar
• Cush JJ Dao KH Malignancy risks with biologic therapies Rheum Dis Clin North Am 2012 38 4 761 770 23137581
   PubMed Web of Science ®Google Scholar
• Nozaki K Silver RM Stickler DE Neurological deficits during treatment with tumor necrosis factor-alpha antagonists Am J Med Sci 2011 342 5 352 355 21876428
   PubMed Web of Science ®Google Scholar
• Erckens RJ Mostard RL Wijnen PA Schouten JS Drent M Adalimumab successful in sarcoidosis patients with refractory chronic non-infectious uveitis Graefes Arch Clin Exp Ophthalmol 2012 250 5 713 720 22119879
   PubMed Web of Science ®Google Scholar
• Baughman RP Lower EE Bradley DA Raymond LA Kaufman A Etanercept for refractory ocular sarcoidosis: results of a double-blind randomized trial Chest 2005 128 2 1062 1047 16100213
   PubMed Web of Science ®Google Scholar
• Utz JP Limper AH Kalra S Etanercept for the treatment of stage II and III progressive pulmonary sarcoidosis Chest 2003 124 1 177 185 12853521
   PubMed Web of Science ®Google Scholar
• Louie GH Chitkara P Ward MM Relapse of sarcoidosis upon treatment with etanercept Ann Rheum Dis 2008 67 6 896 898 18474661
   PubMed Web of Science ®Google Scholar
• van der Stoep D Braunstahl GJ van Zeben J Wouters J Sarcoidosis during anti-tumor necrosis factor-alpha therapy: no relapse after rechallenge J Rheumatol 2009 36 12 2847 2848 19966199
   PubMed Web of Science ®Google Scholar
• Verschueren K Van Essche E Verschueren P Taelman V Westhovens R Development of sarcoidosis in etanercept-treated rheumatoid arthritis patients Clin Rheumatol 2007 26 11 1969 1971 17340045
   PubMed Web of Science ®Google Scholar
• Burns AM Green PJ Pasternak S Etanercept-induced cutaneous and pulmonary sarcoid-like granulomas resolving with adalimumab J Cutan Pathol 2012 39 2 289 293 21899592
   PubMed Web of Science ®Google Scholar
• Baughman RP Judson MA Teirstein AS Moller DR Lower EE Thalidomide for chronic sarcoidosis Chest 2002 122 1 227 232 12114363
   PubMed Web of Science ®Google Scholar
• Baughman RP Judson MA Ingledue R Craft NL Lower EE Efficacy and safety of apremilast in chronic cutaneous sarcoidosis Arch Dermatol 2012 148 2 262 264 22004880
   PubMedGoogle Scholar
• Lower EE Baughman RP Kaufman AH Rituximab for refractory granulomatous eye disease Clin Ophthalmol 2012 6 1613 1618 23055686
   PubMedGoogle Scholar
• Bomprezzi R Pati S Chansakul C Vollmer T A case of neurosarcoidosis successfully treated with rituximab Neurology 2010 75 6 568 570 20697110
   PubMed Web of Science ®Google Scholar
• Bachelez H Senet P Cadranel J Kaoukhov A Dubertret L The use of tetracyclines for the treatment of sarcoidosis Arch Dermatol 2001 137 1 69 73 11176663
   PubMedGoogle Scholar
• Wyser CP van Schalkwyk EM Alheit B Bardin PG Joubert JR Treatment of progressive pulmonary sarcoidosis with cyclosporin A. A randomized controlled trial Am J Respir Crit Care Med 1997 156 5 1371 1376 9372647
   PubMed Web of Science ®Google Scholar
• Stern BJ Schonfeld SA Sewell C Krumholz A Scott P Belendiuk G The treatment of neurosarcoidosis with cyclosporine Arch Neurol 1992 49 10 1065 1072 1329698
   PubMedGoogle Scholar
• Judson MA The management of sarcoidosis by the primary care physician Am J Med 2007 120 5 403 407 17466647
   PubMed Web of Science ®Google Scholar
• Petrache I Moller DR Mechanism of therapy for sarcoidosis Baughman RP Sarcoidosis New York, NY Taylor and Francis Group 2006 210 671 687
   Google Scholar
• Khalil N Whitman C Zuo L Danielpour D Greenberg A Regulation of alveolar macrophage transforming growth factor-beta secretion by corticosteroids in bleomycin-induced pulmonary inflammation in the rat J Clinical Invest 1993 92 4 1812 1818 7691887
   PubMed Web of Science ®Google Scholar
• Chen ES Song Z Willett MH Serum amyloid A regulates granulomatous inflammation in sarcoidosis through Toll-like receptor-2 Am J Respir Crit Care Med 2010 181 4 360 373 19910611
   PubMed Web of Science ®Google Scholar